Is obesity a factor of surgical difficulty in transanal endoscopic surgery?

Xavier Serra-Aracil1, Esther Gil-Barrionuevo1, Raquel Lobato-Gil1

  • 1Department of Colorectal Surgery, Department of General and Digestive Surgery, Parc Taulí University Hospital, Universidad Autonoma de Barcelona (UAB), Parc Taulí S/n, 08208, Sabadell, Barcelona, Spain.

Abstract

Insights

Transanal endoscopic surgery (TES) is feasible in obese patients. This study found no significant differences in postoperative outcomes for obese individuals undergoing TES, indicating it is not a factor of surgical difficulty.

Area of Science:

  • Colorectal Surgery
  • Surgical Oncology
  • Obesity Medicine

Background:

  • Transanal endoscopic surgery (TES) is a minimally invasive technique for rectal tumor removal.
  • Obesity is a growing concern in surgical patient populations.
  • Assessing the safety and efficacy of TES in obese patients is crucial.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of transanal endoscopic surgery (TES) in patients with rectal tumors and a body mass index (BMI) of 30 kg/m² or higher.
  • To compare the surgical outcomes of obese patients undergoing TES with non-obese patients.

Main Methods:

  • An observational, descriptive study was conducted between June 2004 and January 2019.
  • Patients were categorized into two groups: non-obese (BMI < 30 kg/m²) and obese (BMI ≥ 30 kg/m²).
  • Surgical outcomes, including morbidity, operative time, and complication rates, were analyzed and compared between the groups.

Main Results:

  • A total of 681 patients were analyzed, with 145 (21.3%) identified as obese.
  • No statistically significant differences in overall morbidity were observed between obese and non-obese patients (18.6% vs. 27%).
  • Obese patients showed trends towards shorter surgical times, fewer instances of peritoneal cavity perforation, and a lower rate of lesion fragmentation.

Conclusions:

  • Transanal endoscopic surgery (TES) is a feasible surgical option for obese patients with rectal tumors.
  • Obesity (BMI ≥ 30 kg/m²) does not appear to be a significant factor increasing surgical difficulty or negatively impacting postoperative outcomes in TES.
  • The findings support the use of TES in obese individuals, suggesting comparable safety and efficacy to non-obese patients.

Related Concept Videos

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
440
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
190
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
167
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
384